MOONLAKE IMMUNOTHERAPEUTICS
Cash Flow History
| Period | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| Mar 2021 | $-107.8K | $-107.8K | — | — |
| Jun 2021 | $-25.6M | $-25.6M | — | — |
| Sep 2021 | $-2.0M | $-2.0M | — | — |
| Dec 2021 | $-7.6M | $-7.6M | — | — |
| Mar 2022 | $-14.2M | $-14.2M | $16.0K | $2.0M |
| Jun 2022 | $-20.8M | $-20.8M | $-2 | $2.5M |
| Sep 2022 | $-9.4M | $-9.4M | $0 | $2.6M |
| Dec 2022 | $-11.6M | $-11.6M | $1 | $2.6M |
| Mar 2023 | $-9.0M | $-9.0M | $0 | $2.6M |
| Jun 2023 | $-12.2M | $-12.2M | $0 | $1.5M |
| Sep 2023 | $-9.3M | $-9.3M | $0 | $1.4M |
| Dec 2023 | $-12.3M | $-12.6M | $284.0K | $1.6M |
| Mar 2024 | $-14.9M | $-15.2M | $212.0K | $1.7M |
| Jun 2024 | $-27.9M | $-27.9M | $0 | $1.8M |
| Sep 2024 | $-25.3M | $-25.4M | $132.0K | $1.8M |
| Dec 2024 | $-48.5M | $-48.6M | $176.0K | $1.9M |
| Mar 2025 | $-38.1M | $-38.2M | $35.0K | $2.3M |
| Jun 2025 | $-54.5M | $-54.5M | $0 | $3.3M |
| Sep 2025 | $-44.5M | $-44.5M | $0 | $3.7M |
| Dec 2025 | $-58.8M | $-58.8M | $0 | $3.6M |
| Mar 2026 | $-66.3M | $-66.3M | $0 | $13.4M |
| Jun 2026 | $-55.6M | $-55.6M | $0 | $2.5M |